Shopping Cart
Remove All
Your shopping cart is currently empty
5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $98 | - | In Stock | |
| 5 mg | $172 | - | In Stock | |
| 10 mg | $289 | - | In Stock | |
| 25 mg | $579 | - | In Stock | |
| 50 mg | $928 | - | In Stock | |
| 100 mg | $1,490 | - | In Stock | |
| 200 mg | $1,970 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $188 | - | In Stock |
| Description | 5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms. |
| Targets&IC50 | PFKFB4:8.6 μM (Ki) |
| In vitro | In H460 cells, 5MPN (0-30 μM; 24 hours) is able to inhibit the expression of PFKFB4[2]. |
| In vivo | 5MPN (120 mg/kg; p.o.) effectively inhibits the growth of Lewis lung carcinomas (LLC) in C57BL/6 mice and H460 human lung adenocarcinoma xenografts in athymic mice, without impacting body weight. A decline in Ki67-positive cells within LLC xenografts suggests 5MPN interferes with cell cycle progression in vivo[1]. |
| Synonyms | 5-MPN |
| Molecular Weight | 305.33 |
| Formula | C15H19N3O4 |
| Cas No. | 47208-82-2 |
| Smiles | COc1cccc2c(NCCCCCO[N+]([O-])=O)ccnc12 |
| Color | Yellow |
| Appearance | Viscous |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (262.01 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (10.81 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.